跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,161 条关于
“DESTINY-Breast06”
全部
23,161
临床试验
21,629
药物
81
机构
21
资讯
1,430
2年前
Trastuzumab Deruxtecan Preserves Quality of Life and Delays Pain in HR+/HER2-Low/Ultralow Metastatic Breast Cancer
去年
Enhertu Approved for HER2-Low and HER2-Ultralow Metastatic Breast Cancer
去年
Top 5 Most-Read Breast Cancer Articles of 2024 Highlight Advances in Research and Treatment
去年
T-DXd Shows Promise in HER2-Ultra Low Breast Cancer, Expanding Treatment Horizons
去年
FDA Approves Roche's Companion Diagnostic for HER2-Ultralow Metastatic Breast Cancer
2年前
Pathologists Call for Reform in HER2 Testing Standards as Breast Cancer Treatment Landscape Evolves
去年
AstraZeneca's Oncology Innovations and Financial Growth Prospects
去年
Trastuzumab Deruxtecan Improves PFS in HER2-Low/Ultralow Metastatic Breast Cancer Regardless of Endocrine Resistance
去年
Recent Clinical Trial Updates and FDA Actions in Oncology: A Review
去年
SABCS 2024: Key Advances in Breast Cancer Treatment Highlighted
第 1 页,共 143 页
上一页
下一页